http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201228679-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e2b25334178e075b24d9643eb9fdc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8983a064d5a6c9324e4285203084e02a |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate | 2011-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d391f5b403c7f092ccddfcd37541ad5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd10360c709ead8d7894c2f894bea781 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35728ad84ba3554e120c663ddbe20f05 |
| publicationDate | 2012-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201228679-A |
| titleOfInvention | Composition for percutaneous absorption to inhibit appetite |
| abstract | Disclosed is a composition for percutaneous absorption to inhibit appetite, comprising a pharmaceutically effective amount of sibutramine or the pharmaceutically acceptable salts thereof, an transdermal enhancer, and a polymer. The absorption enhancer is selected from one of the group consisting of cocoimidazoline dicarboxylate, sorbitol and propylene glycol, or the combination thereof. The dosage form of the composition comprises transdermal gel, patch or solution. The composition may enhance the skin penetration of sibutramine and hence inhibit the appetite. |
| priorityDate | 2011-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.